Corona Remedies
add_icon

Corona Remedies

1,701.30
-1.70
(-0.10%)
Market Cap
10,405.17 Cr
PE Ratio
56.06
Volume
6,395.00
Day High - Low
1,725.00 - 1,690.10
52W High-Low
1,949.40 - 1,336.60
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
10,405.17 Cr
EPS
30.27
PE Ratio
56.06
PB Ratio
13.90
Book Value
122.12
EBITDA
274.34
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
24.65
Debt to Equity
0.23
Analyst Rating and Forecast
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Corona Remedies Limited will host Non-Deal Roadshow meetings with investors in Singapore on June 8 and 9, 2026. The meetings are organized by IIFL Capital.
neutral
CORONA Remedies Limited will conduct Non-Deal Roadshow meetings on June 4 and 5, 2026, in Mumbai. Discussions will rely on publicly available information.
neutral
Nirav Mehta declared no encumbrance on equity shares for FY 2025-2026. The disclosure was made under SEBI SAST Regulations.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,780.10
#1 4,27,105.62
37.30
#1 58,220.10
6.38
#1 11,565
25.80
42.78
6,596.50
1,75,116.35
67.97
10,560.00
8.73
2,520
13.44
47.99
4,339.90
1,46,881.94
69.16
13,886.20
20.34
2,138
-26.91
48.37
1,398.70
1,12,984.28
28.76
27,711.70
-2.46
3,783
-55.32
58.01
1,084.60
1,09,136.14
21.14
26,719.70
13.65
5,242
7.82
70.26
1,267.50
1,05,791.00
25.35
33,593.30
-0.44
3,998
-86.05
42.70
2,249.80
1,02,825.58
#1 19.30
27,487.50
19.98
5,345
#1 87.72
43.27
2,353.00
97,133.03
50.52
14,277.60
12.03
1,750
31.75
48.78
1,463.60
85,006.13
23.88
33,384.70
3.21
3,376
1.99
54.11
1,427.20
77,048.33
84.57
6,812.90
#1 21.03
884
21.18
79.30
Growth Rate
Revenue Growth
16.70 %
Net Income Growth
26.47 %
Cash Flow Change
21.52 %
ROE
30.84 %
ROCE
38.23 %
EBITDA Margin (Avg.)
-5.13 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
293
316
299
295
349
364
345
358
Expenses
242
247
228
240
277
283
278
291
EBITDA
51
69
70
56
72
81
66
66
Operating Profit %
17 %
21 %
23 %
18 %
20 %
22 %
19 %
18 %
Depreciation
8
9
10
10
9
9
9
10
Interest
3
3
2
2
2
2
2
1
Profit Before Tax
39
57
58
44
61
70
55
55
Tax
9
14
13
12
15
18
14
9
Net Profit
30
43
45
32
46
52
41
45
EPS in ₹
4.90
7.03
7.35
5.16
7.55
8.55
6.75
7.41

Balance Sheet

Balance Sheet
2023
2024
2025
2026
Total Assets
595
831
930
1,205
Fixed Assets
185
384
370
723
Current Assets
292
290
339
348
Capital Work in Progress
65
121
186
143
Investments
32
26
26
125
Other Assets
314
301
348
0
Total Equity & Liabilities
595
831
930
1,205
Current Liabilities
137
224
240
361
Non Current Liabilities
49
126
84
97
Total Equity
409
480
606
747
Reserve & Surplus
347
419
545
686
Share Capital
61
61
61
61

Cash Flow

Cash Flow
2023
2024
2025
Net Cash Flow
8
-11
0
Investing Activities
-50
-267
-84
Operating Activities
103
157
191
Financing Activities
-45
99
-107

Share Holding

% Holding
Apr 2025
Dec 2025
Mar 2026
Promoter
72.50 %
69.00 %
69.00 %
FIIs
0.00 %
1.84 %
2.25 %
DIIs
0.00 %
6.76 %
7.02 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
1.36 %
0.77 %
Others
27.50 %
21.05 %
20.97 %
No of Share Holders
9
9
19,609

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.31 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.47 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
19 Jun 2026 DIVIDEND Dividend
₹ 10.00 /share
19 Jun 2026 1,712.15 1,703.00
02 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
02 Jan 2026 1,347.70 1,402.95
02 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
02 Feb 2026 1,404.80 1,447.75
11 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 May 2026 1,689.20 1,712.15

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation1 day ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation3 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release7 days ago
General-UpdatesMay 21, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 19, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 18, 2026
Annual Secretarial Compliance Report For The Financial Year Ended March 31 2026May 12, 2026
Annual Secretarial Compliance Report For The Financial Year Ended March 31 2026May 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 12, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 12, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 11, 2026
Record Date For The Purpose Of Final Dividend For The F.Y. 2025-26 Is June 19 2026May 11, 2026
Corporate Action-Board approves DividendMay 11, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 11, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 11, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 11, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 11, 2026
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMay 11, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 11, 2026
Financial Results For The Fourth Quarter And Year Ended March 31 2026May 11, 2026
Board Meeting Outcome for Outcome Of Board MeetingMay 11, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 30, 2026
Board Meeting Intimation for Consideration And Approval Of Audited Financial Results On Standalone And Consolidated Basis For The Fourth Quarter And Year Ended On March 31 2026 Apr 30, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 30, 2026
Closure of Trading WindowMar 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 03, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 03, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 02, 2026
Announcement under Regulation 30 (LODR)-Credit RatingFeb 02, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 02, 2026
Financial Results For The Third Quarter And Nine Months Ended December 31 2025Feb 02, 2026
Board Meeting Outcome for Outcome Of Board MeetingFeb 02, 2026
Intimation Of Violation Under The Companys Code Of Conduct For Regulating Monitoring And Reporting Of Insider Trading In Securities And The SEBI (Prohibition Of Insider Trading) Regulations 2015Jan 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 28, 2026
Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results On Standalone And Consolidated Basis For The Third Quarter And Nine Months Ended On December 31 2025Jan 27, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 21, 2026
Intimation Under Regulation 30-GMP Certificate Of Compliance From Eurasian Economic UnionJan 19, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 12, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 05, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 03, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 03, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 02, 2026
Financial Results For The Second Quarter And Half Year Ended September 30 2025Jan 02, 2026
Board Meeting Outcome for Outcome Of Board MeetingJan 02, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
ICICI Prudential Quality Fund Direct-Growth
0.00%
-14027
-0.11%
-0.59%
WhiteOak Capital Consumption Opportunities Fund Direct-Growth
1.53%
616
0.01%
0.09%
Invesco India Multicap Fund Direct-Growth
1.21%
0
0.00%
0.23%
Kotak Healthcare Fund Direct-Growth
1.91%
0
0.00%
-0.02%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.05%
0
0.00%
0.00%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
DSP Healthcare Fund Direct-Growth
0.15%
0
0.00%
-0.48%
Edelweiss Recently Listed IPO Fund Direct-Growth
1.93%
0
0.00%
-0.16%
Franklin India Large & Mid Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Groww Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
HDFC Pharma And Healthcare Fund Direct-Growth
0.00%
0
0.00%
0.00%
Axis Business Cycles Fund Direct-Growth
0.65%
0
0.00%
0.00%
Invesco India Consumption Fund Direct-Growth
2.52%
0
0.01%
0.25%
Invesco India ELSS Tax Saver Fund Direct-Growth
0.65%
0
0.00%
0.31%
Invesco India Large & Mid Cap Fund Direct-Growth
0.44%
0
0.00%
-0.02%
Invesco India Mid Cap Fund Direct-Growth
1.03%
0
0.00%
-0.07%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
2.24%
0
0.00%
0.12%
Invesco India Smallcap Fund Direct-Growth
2.19%
0
0.00%
-0.18%
Axis Equity Savings Fund Direct-Growth
0.79%
0
0.00%
0.06%
Mirae Asset Healthcare Fund Direct-Growth
0.00%
0
0.00%
0.00%
Kotak Consumption Fund Direct-Growth
0.60%
0
0.00%
0.00%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Motilal Oswal Nifty Microcap 250 Index Fund Direct-Growth
0.09%
0
0.00%
-0.01%
SBI Healthcare Opportunities Fund Direct Plan-Growth
0.00%
0
0.00%
-0.29%
Tata India Pharma & Healthcare Fund Direct-Growth
0.77%
0
0.00%
0.02%

Technical Indicators

RSI(14)
Neutral
51.19
ATR(14)
Less Volatile
73.77
STOCH(9,6)
Oversold
15.80
STOCH RSI(14)
Oversold
17.32
MACD(12,26)
Bearish
-9.63
ADX(14)
Strong Trend
25.34
UO(9)
Bearish
31.76
ROC(12)
Downtrend And Accelerating
-4.18
WillR(14)
Neutral
-77.52